Are you an EPFL student looking for a semester project?
Work with us on data science and visualisation projects, and deploy your project as an app on top of Graph Search.
Adenoviruses (AdVs) are prevalent and give rise to chronic and re-current disease. Human AdV (HAdV) species B and C, such as HAdV-C2, -C5, and-B14, cause respiratory disease and constitute a health threat for immunocom-promised individuals. HAdV-Cs are well known for lysing cells owing to the E3CR1--encoded adenovirus death protein (ADP). We previously reported a high-throughput image-based screening framework and identified an inhibitor ofHAdV-C2 multiround infection, nelfinavir mesylate. Nelfinavir is the active ingre-dient of Viracept, an FDA-approved inhibitor of human immunodeficiency virus(HIV) aspartyl protease that is used to treat AIDS. It is not effective againstsingle-round HAdV infections. Here, we show that nelfinavir inhibits lytic cell-freetransmission of HAdV, indicated by the suppression of comet-shaped infectionfoci in cell culture. Comet-shaped foci occur upon convection-based transmissionof cell-free viral particles from an infected cell to neighboring uninfected cells.HAdV lacking ADP was insensitive to nelfinavir but gave rise to comet-shapedfoci, indicating that ADP enhances but is not required for cell lysis. This was sup-ported by the notion that HAdV-B14 and -B14p1 lacking ADP were highly sensi-tive to nelfinavir, although HAdV-A31, -B3, -B7, -B11, -B16, -B21, -D8, -D30, and-D37 were less sensitive. Conspicuously, nelfinavir uncovered slow-growinground HAdV-C2 foci, independent of neutralizing antibodies in the medium, in-dicative of nonlytic cell-to-cell transmission. Our study demonstrates the repur-posing potential of nelfinavir with postexposure efficacy against different HAdVsand describes an alternative nonlytic cell-to-cell transmission mode of HAdV.
, , , ,